BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.6% - Here's Why

Key Points

• BioRestorative Therapies (OTCMKTS:BRTXQ) shares fell by 1.6%, trading at $1.58 after previously closing at $1.60, indicating a significant decline in investor interest.
• The company's trading volume dropped drastically to 16,063 shares, a sharp decline from its average volume of 62,169,492 shares.
• BioRestorative Therapies specializes in therapeutic products using adult stem cells, with its primary programs focused on treating disc/spine disease and metabolic disorders.

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - ) shares traded down 1.6% during mid-day trading on Friday . The company traded as low as $1.57 and last traded at $1.58. 16,063 shares were traded during trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.60.

BioRestorative Therapies Trading Down 1.6%

The stock's 50-day moving average is $1.56 and its 200-day moving average is $1.63. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of -1.47 and a beta of 102.36.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.